GET THE APP
KEAP1 aberrant methylation is a novel marker of patients outcome in malignant gliomas
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

KEAP1 aberrant methylation is a novel marker of patients outcome in malignant gliomas


International Conference & Exhibition on Cancer Science & Therapy

15-17 August 2011 Las Vegas, USA

Paola Parrella

Posters & Accepted Abstracts: J Cancer Sci Ther

PDF HTML

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Citation image
Cancer Science & Therapy peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment
Advances in NKT cell Immunotherapy for Glioblastoma.

View More »

 

Open Access Journals

arrow_upward arrow_upward